1 year return (CAGR)
48.39%
Greenwich Lifesciences Inc Exchange (NASDAQ, USD)
GLSI
18.22
-1.97 (-10.11%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
25.07%
5 year return (CAGR)
-15.98%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
257.02M
Price/Sales
72235.93
Ent value
253.90M
Price/Book
82.46
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
48.79%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 19.31 |
| Daily high | 19.31 |
| Daily low | 17.12 |
| Daily Volume | 187K |
| All-time high | 72.22 |
| 1y analyst estimate | 57.00 |
| Beta | 1.45 |
| EPS (TTM) | -1.48 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| GLSI | S&P500 | |
| Current price drop from All-time high | -74.77% | -0.84% |
| Highest price drop | -90.11% | -56.47% |
| Date of highest drop | 16 Jun 2022 | 9 Mar 2009 |
| Avg drop from high | -72.58% | -10.68% |
| Avg time to new high | 150 days | 12 days |
| Max time to new high | 1452 days | 1805 days |
News
